Drw Securities, LLC Aurinia Pharmaceuticals Inc. Transaction History

Drw Securities, LLC

  • $3.55 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$8.96 - $11.69 $169,361 - $220,964
-18,902 Reduced 43.01%
25,050 $242,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $261,074 - $495,339
43,952 New
43,952 $482,000
Q3 2018

Nov 14, 2018
SELL
$5.27 - $6.64 $164,951 - $207,832
-31,300 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$4.85 - $5.99 $151,805 - $187,487
31,300 New
31,300 $162,000

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.26B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email